Clinical trial Recruiting at 1 site Observational Ages 18 and up

Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups

Official title: Advancing Bulbar Assessment in Inclusion Body Myositis Through a Multimodal Imaging Approach

Run by Johns Hopkins University · NCT07823101 · Data updated 2026-11-12

This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedNovember 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 28, 2026
Trial IDNCT07823101 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with a confirmed IBM diagnosis or related neuromuscular conditions, plus healthy controls.

Probably not a fit

Patients whose bulbar dysfunction does not correlate with imaging findings or who cannot complete the imaging procedures may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses neuromuscular ultrasound and MRI to identify imaging biomarkers of bulbar dysfunction in IBM. It compares imaging findings with those from other myopathies, ALS, PLS, and healthy controls during a one-time visit that may include neurological exams, swallowing questionnaires, tongue strength testing, and imaging. The goal is to find sensitive, objective markers that reflect dysphagia and bulbar involvement.

Why it matters

Potential benefit: If successful, participants may gain better understanding of bulbar involvement through imaging markers that could help guide future assessments.

How similar studies have gone: Previous work has explored imaging markers in neuromuscular diseases, but this study expands to IBM and includes comparative groups.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must have a confirmed diagnosis of inclusion body myositis (IBM), amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), or myopathy in accordance with the respective diagnostic criteria.
* Participants with disease must have clinically relevant laboratory testing for disease biomarkers (e.g., Creatine Kinase (CK), Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC)) within the last 12 months.
* Participants must be able to remain supine for 30 minutes or longer and cannot have significant breathing difficulties.
* Healthy controls must not have any neuromuscular disease.

Exclusion Criteria:

* Unable or unwilling to provide written informed consent.
* Medical history or clinically significant physical examination or laboratory results that, in the opinion of the investigator, would render the participant unsuitable for the study.
* Participants who are unlikely to comply with the study protocol or, in the opinion of the investigator, would not be a suitable candidate for participation in the study.
* Patients with IBM, ALS, or myopathy who have another known neuromuscular condition with known bulbar involvement.
* Any patient who has undergone a procedure for dysphagia, including myotomy, dilatation, or Botox.

Where it's running

  • The Johns Hopkins Hospital
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Abdullah Z AlQahtani, MD MPH — the Johns Hopkins School of Medicine
  • Study coordinator: Joseph D Niang, B.A.
  • Email: jniang1@jh.edu
  • Phone: 410-570-3949

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.